
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $40.1M | $45.7M | $47.4M | $40.4M | $50.3M | |
Revenue Growth (YoY) | 35.94% | 13.8% | 3.8% | -14.78% | 24.61% | |
Cost of Revenues | $29.1M | $25.1M | $32.6M | $25M | $36.2M | |
Gross Profit | $11M | $20.6M | $14.8M | $15.4M | $14.2M | |
Gross Profit Margin | 27.37% | 45.14% | 31.31% | 38.23% | 28.15% | |
R&D Expenses | $3.9M | $16.3M | $18.7M | $10.8M | $9.6M | |
Selling, General & Admin | $11.8M | $18.1M | $18M | $21.8M | $22.8M | |
Other Inc / (Exp) | $228.9K | $404.5K | $2.5M | -$3.2M | -$26.2M | |
Operating Expenses | $15.7M | $34.4M | $36.6M | $32.6M | $32.5M | |
Operating Income | -$4.8M | -$13.8M | -$21.8M | -$17.2M | -$18.3M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$4.4M | -$13.3M | -$19.2M | -$19.6M | -$43.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $129K | $129K | $144K | $156K | $170K | |
Net Income to Company | -$4.5M | -$13.5M | -$19.3M | -$19.7M | -$43.9M | |
Minority Interest in Earnings | $119.8K | $35.5K | $350 | -- | -- | |
Net Income to Common Excl Extra Items | -$4.4M | -$13.4M | -$19.3M | -$19.7M | -$43.9M | |
Basic EPS (Cont. Ops) | -$0.05 | -$0.15 | -$0.21 | -$0.18 | -$0.33 | |
Diluted EPS (Cont. Ops) | -$0.05 | -$0.15 | -$0.21 | -$0.18 | -$0.33 | |
Weighted Average Basic Share | $82.3M | $88.8M | $91.4M | $109M | $132.9M | |
Weighted Average Diluted Share | $82.3M | $88.8M | $91.4M | $109M | $132.9M | |
EBITDA | -$4.1M | -$13.1M | -$21.1M | -$16.6M | -$17.7M | |
EBIT | -$4.8M | -$13.8M | -$21.8M | -$17.2M | -$18.3M | |
Revenue (Reported) | $40.1M | $45.7M | $47.4M | $40.4M | $50.3M | |
Operating Income (Reported) | -$4.8M | -$13.8M | -$21.8M | -$17.2M | -$18.3M | |
Operating Income (Adjusted) | -$4.8M | -$13.8M | -$21.8M | -$17.2M | -$18.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $11.7M | $11.6M | $10.8M | $10M | $10.5M | |
Revenue Growth (YoY) | 48.2% | -0.84% | -7.08% | -6.74% | 5.04% | |
Cost of Revenues | $6.4M | $7.8M | $6.6M | $8.5M | $7.6M | |
Gross Profit | $5.3M | $3.8M | $4.1M | $1.5M | $2.9M | |
Gross Profit Margin | 45.22% | 32.78% | 38.43% | 14.86% | 27.6% | |
R&D Expenses | $3.6M | $5.4M | $2.3M | $2.1M | $2.1M | |
Selling, General & Admin | $5.9M | $4.5M | $4.6M | $7.2M | $4.7M | |
Other Inc / (Exp) | $27.8K | $4.7M | $134.9K | -$24.9M | $400K | |
Operating Expenses | $9.5M | $9.9M | $7M | $9.3M | $6.8M | |
Operating Income | -$4.2M | -$6.1M | -$2.8M | -$7.8M | -$3.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$4.2M | -$1.3M | -$2.6M | -$32.5M | -$3.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $33K | $36K | $39K | -- | $52K | |
Net Income to Company | -$4.2M | -$1.4M | -$2.6M | -$32.5M | -$3.1M | |
Minority Interest in Earnings | $39.5K | $20 | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$4.1M | -$1.4M | -$2.6M | -$32.5M | -$3.1M | |
Basic EPS (Cont. Ops) | -$0.05 | -$0.02 | -$0.03 | -$0.27 | -$0.02 | |
Diluted EPS (Cont. Ops) | -$0.05 | -$0.02 | -$0.03 | -$0.27 | -$0.02 | |
Weighted Average Basic Share | $87.4M | $90.1M | $105M | $120.1M | $166.1M | |
Weighted Average Diluted Share | $87.4M | $90.1M | $105M | $120.1M | $166.1M | |
EBITDA | -$4M | -$5.8M | -$2.6M | -$7.6M | -$3.7M | |
EBIT | -$4.2M | -$6.1M | -$2.8M | -$7.8M | -$3.9M | |
Revenue (Reported) | $11.7M | $11.6M | $10.8M | $10M | $10.5M | |
Operating Income (Reported) | -$4.2M | -$6.1M | -$2.8M | -$7.8M | -$3.9M | |
Operating Income (Adjusted) | -$4.2M | -$6.1M | -$2.8M | -$7.8M | -$3.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $43.9M | $45.6M | $46.6M | $39.7M | $50.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $29.9M | $26.4M | $31.4M | $26.9M | $35.3M | |
Gross Profit | $14M | $19.1M | $15.2M | $12.8M | $15.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $5.1M | $18.1M | $15.6M | $10.6M | $9.7M | |
Selling, General & Admin | $14.3M | $16.7M | $18.1M | $24.4M | $20.3M | |
Other Inc / (Exp) | $417K | $5.1M | -$2.1M | -$28.3M | -$936.8K | |
Operating Expenses | $19.4M | $34.8M | $33.7M | $35M | $30M | |
Operating Income | -$5.4M | -$15.7M | -$18.5M | -$22.2M | -$14.4M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$4.9M | -$10.5M | -$20.4M | -$49.6M | -$14.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $133K | $132K | $147K | $117K | $222K | |
Net Income to Company | -$5.1M | -$10.7M | -$20.6M | -$49.7M | -$14.4M | |
Minority Interest in Earnings | $97.8K | -$4K | $300 | -- | -- | |
Net Income to Common Excl Extra Items | -$5M | -$10.7M | -$20.6M | -$49.7M | -$14.4M | |
Basic EPS (Cont. Ops) | -$0.05 | -$0.12 | -$0.23 | -$0.42 | -$0.09 | |
Diluted EPS (Cont. Ops) | -$0.05 | -$0.12 | -$0.23 | -$0.42 | -$0.09 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$4.7M | -$14.9M | -$17.9M | -$21.6M | -$13.7M | |
EBIT | -$5.4M | -$15.7M | -$18.5M | -$22.2M | -$14.4M | |
Revenue (Reported) | $43.9M | $45.6M | $46.6M | $39.7M | $50.8M | |
Operating Income (Reported) | -$5.4M | -$15.7M | -$18.5M | -$22.2M | -$14.4M | |
Operating Income (Adjusted) | -$5.4M | -$15.7M | -$18.5M | -$22.2M | -$14.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $11.7M | $11.6M | $10.8M | $10M | $10.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $6.4M | $7.8M | $6.6M | $8.5M | $7.6M | |
Gross Profit | $5.3M | $3.8M | $4.1M | $1.5M | $2.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $3.6M | $5.4M | $2.3M | $2.1M | $2.1M | |
Selling, General & Admin | $5.9M | $4.5M | $4.6M | $7.2M | $4.7M | |
Other Inc / (Exp) | $27.8K | $4.7M | $134.9K | -$24.9M | $400K | |
Operating Expenses | $9.5M | $9.9M | $7M | $9.3M | $6.8M | |
Operating Income | -$4.2M | -$6.1M | -$2.8M | -$7.8M | -$3.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$4.2M | -$1.3M | -$2.6M | -$32.5M | -$3.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $33K | $36K | $39K | -- | $52K | |
Net Income to Company | -$4.2M | -$1.4M | -$2.6M | -$32.5M | -$3.1M | |
Minority Interest in Earnings | $39.5K | $20 | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$4.1M | -$1.4M | -$2.6M | -$32.5M | -$3.1M | |
Basic EPS (Cont. Ops) | -$0.05 | -$0.02 | -$0.03 | -$0.27 | -$0.02 | |
Diluted EPS (Cont. Ops) | -$0.05 | -$0.02 | -$0.03 | -$0.27 | -$0.02 | |
Weighted Average Basic Share | $87.4M | $90.1M | $105M | $120.1M | $166.1M | |
Weighted Average Diluted Share | $87.4M | $90.1M | $105M | $120.1M | $166.1M | |
EBITDA | -$4M | -$5.8M | -$2.6M | -$7.6M | -$3.7M | |
EBIT | -$4.2M | -$6.1M | -$2.8M | -$7.8M | -$3.9M | |
Revenue (Reported) | $11.7M | $11.6M | $10.8M | $10M | $10.5M | |
Operating Income (Reported) | -$4.2M | -$6.1M | -$2.8M | -$7.8M | -$3.9M | |
Operating Income (Adjusted) | -$4.2M | -$6.1M | -$2.8M | -$7.8M | -$3.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $17.1M | $26.8M | $8.3M | $5.7M | $14.2M | |
Short Term Investments | $3.6M | $2.5M | $4.4M | $11.7M | $21.4M | |
Accounts Receivable, Net | $9.3M | $12.1M | $6.5M | $9.7M | $11.9M | |
Inventory | $4.5M | $6.6M | $6.4M | $7.6M | $6.1M | |
Prepaid Expenses | $205.6K | $160.6K | $105.5K | $85.6K | -- | |
Other Current Assets | $1.3M | $1.8M | $1.1M | $1.2M | $1.2M | |
Total Current Assets | $39.5M | $52.2M | $30.9M | $39.8M | $62.8M | |
Property Plant And Equipment | $3.4M | $5.7M | $5M | $4.7M | $4.2M | |
Long-Term Investments | $4.5M | $4.9M | $7.7M | $4.7M | $3.6M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $162.5K | $170.9K | $170.1K | $124.9K | $123.8K | |
Total Assets | $47.5M | $63M | $43.8M | $49.3M | $70.8M | |
Accounts Payable | $5.6M | $5.5M | $5.4M | $4.9M | $5.9M | |
Accrued Expenses | $4.3M | $4.1M | $6M | $7.7M | $36.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $982.4K | $701.2K | $786.9K | $651.5K | $639.6K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $16.9M | $17.5M | $14.5M | $15.9M | $43.9M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $19.3M | $23.4M | $19.8M | $19.8M | $47.5M | |
Common Stock | $880.1K | $900.7K | $929.5K | $1.1M | $1.6M | |
Other Common Equity Adj | $1.5M | $1.4M | $1.2M | $1.2M | $2M | |
Common Equity | $28.4M | $39.8M | $24.2M | $29.5M | $23.3M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -$136.8K | -$172.3K | -$172.7K | -- | -- | |
Total Equity | $28.3M | $39.6M | $24M | $29.5M | $23.3M | |
Total Liabilities and Equity | $47.5M | $63M | $43.8M | $49.3M | $70.8M | |
Cash and Short Terms | $20.7M | $29.3M | $12.6M | $17.4M | $35.6M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $32.2M | $21.9M | $8.6M | $14.1M | $15.3M | |
Short Term Investments | $3.4M | $4.5M | $21M | $6.9M | $16.2M | |
Accounts Receivable, Net | $7.8M | $6.8M | $5.6M | $6.8M | $7.2M | |
Inventory | $5.5M | $7.1M | $6.8M | $6.1M | $6.1M | |
Prepaid Expenses | $225.8K | $119.2K | $127.3K | $86.6K | -- | |
Other Current Assets | $1.8M | $2.1M | $1.6M | $1.5M | $1.9M | |
Total Current Assets | $52M | $45M | $46.8M | $42M | $57.1M | |
Property Plant And Equipment | $3.2M | $5.6M | $4.8M | $4.5M | $4.3M | |
Long-Term Investments | $4.5M | $9.6M | $7.7M | $4.6M | $3.5M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $162.5K | $170.9K | $169.1K | $124.9K | $123.8K | |
Total Assets | $59.9M | $60.3M | $59.5M | $51.3M | $65M | |
Accounts Payable | $5.6M | $5.9M | $3.8M | $9M | $3.4M | |
Accrued Expenses | $4.5M | $5.8M | $5.1M | $30.2M | $36.4M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $886.6K | $658.3K | $790.6K | $628K | $614.4K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $15.5M | $17.1M | $11.8M | $42.5M | $40.9M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $17.7M | $21.6M | $16.6M | $46.3M | $44.4M | |
Common Stock | $889.5K | $902.2K | $1.1M | $1.2M | $1.6M | |
Other Common Equity Adj | $1.5M | $1.3M | $1.2M | $1.2M | $1.8M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -$176.3K | -$172.4K | -- | -- | -- | |
Total Equity | $42.2M | $38.7M | $42.9M | $4.9M | $20.7M | |
Total Liabilities and Equity | $59.9M | $60.3M | $59.5M | $51.3M | $65M | |
Cash and Short Terms | $35.6M | $26.3M | $29.6M | $21.1M | $31.5M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$4.5M | -$13.5M | -$19.3M | -$19.7M | -$43.9M | |
Depreciation & Amoritzation | $651.1K | $668.7K | $722K | $608.2K | $636.6K | |
Stock-Based Compensation | $821.1K | $4.4M | $1.3M | $3.9M | $3.3M | |
Change in Accounts Receivable | -$5.6M | -$2M | $5M | -$4.5M | -$5.5M | |
Change in Inventories | -$1.3M | -$2.7M | -$2M | -$2.3M | -$922.6K | |
Cash From Operations | -$4.4M | -$10.7M | -$17.7M | -$15.3M | -$14.2M | |
Capital Expenditures | $542.9K | $1M | $832.7K | $949.5K | $815.3K | |
Cash Acquisitions | -- | -- | -$500K | -- | -- | |
Cash From Investing | $11.8M | $53.7K | -$3.3M | -$8.1M | -$10.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$139.9K | -$602.1K | -$198.7K | -- | -$266.9K | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $3.7M | $20.4M | $2.7M | $21.3M | $33.5M | |
Beginning Cash (CF) | $6M | $17.1M | $26.8M | $8.3M | $6.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $11.1M | $9.8M | -$18.3M | -$2.1M | $9M | |
Ending Cash (CF) | $17.1M | $26.8M | $8.3M | $6.2M | $15.2M | |
Levered Free Cash Flow | -$5M | -$11.8M | -$18.5M | -$16.2M | -$15M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$4.2M | -$1.4M | -$2.6M | -$32.5M | -$3.1M | |
Depreciation & Amoritzation | $205K | $267.6K | $224.6K | $195.4K | $219.5K | |
Stock-Based Compensation | $2.6M | $656.1K | $194.2K | $734.9K | $774.4K | |
Change in Accounts Receivable | $3.7M | $5.5M | $513.8K | $905.4K | $2.5M | |
Change in Inventories | -$1.4M | -$1.2M | -$665.6K | $695K | -$444.7K | |
Cash From Operations | -$245.3K | -$2.3M | -$4.2M | -$3.1M | -$3.4M | |
Capital Expenditures | $346.4K | $524.4K | $216.6K | $245.4K | $500.5K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$146.5K | -$2.5M | -$16.8M | $4.5M | $4.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$32.7K | -$95.6K | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $15.5M | -$95.6K | $21.3M | $7.2M | -- | |
Beginning Cash (CF) | $17.1M | $26.8M | $8.3M | $6.2M | $15.2M | |
Foreign Exchange Rate Adjustment | -$5.2K | -$17.8K | $4.2K | -$2.2K | -$590 | |
Additions / Reductions | $15.1M | -$4.9M | $320.1K | $8.7M | $1.2M | |
Ending Cash (CF) | $32.2M | $21.9M | $8.6M | $14.9M | $16.4M | |
Levered Free Cash Flow | -$591.7K | -$2.8M | -$4.4M | -$3.4M | -$3.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$5.1M | -$10.7M | -$20.6M | -$49.7M | -$14.4M | |
Depreciation & Amoritzation | $685.3K | $731.3K | $679K | $579K | $660.7K | |
Stock-Based Compensation | $3.3M | $2.5M | $805.8K | $4.4M | $3.4M | |
Change in Accounts Receivable | -$1.7M | -$126.2K | -$39.6K | -$4.1M | -$3.9M | |
Change in Inventories | -$2.4M | -$2.5M | -$1.5M | -$894.8K | -$2.1M | |
Cash From Operations | -$794K | -$12.8M | -$19.6M | -$14.2M | -$14.5M | |
Capital Expenditures | $733.4K | $1.2M | $525K | $978.3K | $1.1M | |
Cash Acquisitions | -- | -- | -$500K | -- | -- | |
Cash From Investing | $5.5M | -$2.3M | -$17.6M | $13.2M | -$10.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$172.6K | -$665K | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $19.2M | $4.9M | $24.1M | $7.2M | $26.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $23.8M | -$10.2M | -$13.1M | $6.3M | $1.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$1.5M | -$14M | -$20.1M | -$15.2M | -$15.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$4.2M | -$1.4M | -$2.6M | -$32.5M | -$3.1M | |
Depreciation & Amoritzation | $205K | $267.6K | $224.6K | $195.4K | $219.5K | |
Stock-Based Compensation | $2.6M | $656.1K | $194.2K | $734.9K | $774.4K | |
Change in Accounts Receivable | $3.7M | $5.5M | $513.8K | $905.4K | $2.5M | |
Change in Inventories | -$1.4M | -$1.2M | -$665.6K | $695K | -$444.7K | |
Cash From Operations | -$245.3K | -$2.3M | -$4.2M | -$3.1M | -$3.4M | |
Capital Expenditures | $346.4K | $524.4K | $216.6K | $245.4K | $500.5K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$146.5K | -$2.5M | -$16.8M | $4.5M | $4.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$32.7K | -$95.6K | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $15.5M | -$95.6K | $21.3M | $7.2M | -- | |
Beginning Cash (CF) | $17.1M | $26.8M | $8.3M | $6.2M | $15.2M | |
Foreign Exchange Rate Adjustment | -$5.2K | -$17.8K | $4.2K | -$2.2K | -$590 | |
Additions / Reductions | $15.1M | -$4.9M | $320.1K | $8.7M | $1.2M | |
Ending Cash (CF) | $32.2M | $21.9M | $8.6M | $14.9M | $16.4M | |
Levered Free Cash Flow | -$591.7K | -$2.8M | -$4.4M | -$3.4M | -$3.9M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.